Report Detail
Global Ceftriaxone Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4625141 |
- 10 September, 2025 |
- Global |
- 101 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Ceftriaxone market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Ceftriaxone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ceftriaxone market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Ceftriaxone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Ceftriaxone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Ceftriaxone market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ceftriaxone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ceftriaxone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hikma Pharmaceuticals, Qilu Pharmaceutical, Novartis, Baxter International, Aurobindo Pharma, ACS DOBFAR, Orchid Pharma, Nectar Lifesciences, Lupin Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ceftriaxone market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Intravenous Injection
Intramuscular Injection
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players covered
Hikma Pharmaceuticals
Qilu Pharmaceutical
Novartis
Baxter International
Aurobindo Pharma
ACS DOBFAR
Orchid Pharma
Nectar Lifesciences
Lupin Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ceftriaxone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ceftriaxone, with price, sales quantity, revenue, and global market share of Ceftriaxone from 2020 to 2025.
Chapter 3, the Ceftriaxone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ceftriaxone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Ceftriaxone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ceftriaxone.
Chapter 14 and 15, to describe Ceftriaxone sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Ceftriaxone Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Intravenous Injection
- 1.3.3 Intramuscular Injection
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Ceftriaxone Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 Online Pharmacies
- 1.5 Global Ceftriaxone Market Size & Forecast
- 1.5.1 Global Ceftriaxone Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Ceftriaxone Sales Quantity (2020-2031)
- 1.5.3 Global Ceftriaxone Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Hikma Pharmaceuticals
- 2.1.1 Hikma Pharmaceuticals Details
- 2.1.2 Hikma Pharmaceuticals Major Business
- 2.1.3 Hikma Pharmaceuticals Ceftriaxone Product and Services
- 2.1.4 Hikma Pharmaceuticals Ceftriaxone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Hikma Pharmaceuticals Recent Developments/Updates
- 2.2 Qilu Pharmaceutical
- 2.2.1 Qilu Pharmaceutical Details
- 2.2.2 Qilu Pharmaceutical Major Business
- 2.2.3 Qilu Pharmaceutical Ceftriaxone Product and Services
- 2.2.4 Qilu Pharmaceutical Ceftriaxone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Qilu Pharmaceutical Recent Developments/Updates
- 2.3 Novartis
- 2.3.1 Novartis Details
- 2.3.2 Novartis Major Business
- 2.3.3 Novartis Ceftriaxone Product and Services
- 2.3.4 Novartis Ceftriaxone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Novartis Recent Developments/Updates
- 2.4 Baxter International
- 2.4.1 Baxter International Details
- 2.4.2 Baxter International Major Business
- 2.4.3 Baxter International Ceftriaxone Product and Services
- 2.4.4 Baxter International Ceftriaxone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Baxter International Recent Developments/Updates
- 2.5 Aurobindo Pharma
- 2.5.1 Aurobindo Pharma Details
- 2.5.2 Aurobindo Pharma Major Business
- 2.5.3 Aurobindo Pharma Ceftriaxone Product and Services
- 2.5.4 Aurobindo Pharma Ceftriaxone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Aurobindo Pharma Recent Developments/Updates
- 2.6 ACS DOBFAR
- 2.6.1 ACS DOBFAR Details
- 2.6.2 ACS DOBFAR Major Business
- 2.6.3 ACS DOBFAR Ceftriaxone Product and Services
- 2.6.4 ACS DOBFAR Ceftriaxone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 ACS DOBFAR Recent Developments/Updates
- 2.7 Orchid Pharma
- 2.7.1 Orchid Pharma Details
- 2.7.2 Orchid Pharma Major Business
- 2.7.3 Orchid Pharma Ceftriaxone Product and Services
- 2.7.4 Orchid Pharma Ceftriaxone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Orchid Pharma Recent Developments/Updates
- 2.8 Nectar Lifesciences
- 2.8.1 Nectar Lifesciences Details
- 2.8.2 Nectar Lifesciences Major Business
- 2.8.3 Nectar Lifesciences Ceftriaxone Product and Services
- 2.8.4 Nectar Lifesciences Ceftriaxone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Nectar Lifesciences Recent Developments/Updates
- 2.9 Lupin Pharmaceuticals
- 2.9.1 Lupin Pharmaceuticals Details
- 2.9.2 Lupin Pharmaceuticals Major Business
- 2.9.3 Lupin Pharmaceuticals Ceftriaxone Product and Services
- 2.9.4 Lupin Pharmaceuticals Ceftriaxone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Lupin Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Ceftriaxone by Manufacturer
- 3.1 Global Ceftriaxone Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Ceftriaxone Revenue by Manufacturer (2020-2025)
- 3.3 Global Ceftriaxone Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Ceftriaxone by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Ceftriaxone Manufacturer Market Share in 2024
- 3.4.3 Top 6 Ceftriaxone Manufacturer Market Share in 2024
- 3.5 Ceftriaxone Market: Overall Company Footprint Analysis
- 3.5.1 Ceftriaxone Market: Region Footprint
- 3.5.2 Ceftriaxone Market: Company Product Type Footprint
- 3.5.3 Ceftriaxone Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Ceftriaxone Market Size by Region
- 4.1.1 Global Ceftriaxone Sales Quantity by Region (2020-2031)
- 4.1.2 Global Ceftriaxone Consumption Value by Region (2020-2031)
- 4.1.3 Global Ceftriaxone Average Price by Region (2020-2031)
- 4.2 North America Ceftriaxone Consumption Value (2020-2031)
- 4.3 Europe Ceftriaxone Consumption Value (2020-2031)
- 4.4 Asia-Pacific Ceftriaxone Consumption Value (2020-2031)
- 4.5 South America Ceftriaxone Consumption Value (2020-2031)
- 4.6 Middle East & Africa Ceftriaxone Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Ceftriaxone Sales Quantity by Type (2020-2031)
- 5.2 Global Ceftriaxone Consumption Value by Type (2020-2031)
- 5.3 Global Ceftriaxone Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Ceftriaxone Sales Quantity by Application (2020-2031)
- 6.2 Global Ceftriaxone Consumption Value by Application (2020-2031)
- 6.3 Global Ceftriaxone Average Price by Application (2020-2031)
7 North America
- 7.1 North America Ceftriaxone Sales Quantity by Type (2020-2031)
- 7.2 North America Ceftriaxone Sales Quantity by Application (2020-2031)
- 7.3 North America Ceftriaxone Market Size by Country
- 7.3.1 North America Ceftriaxone Sales Quantity by Country (2020-2031)
- 7.3.2 North America Ceftriaxone Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Ceftriaxone Sales Quantity by Type (2020-2031)
- 8.2 Europe Ceftriaxone Sales Quantity by Application (2020-2031)
- 8.3 Europe Ceftriaxone Market Size by Country
- 8.3.1 Europe Ceftriaxone Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Ceftriaxone Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Ceftriaxone Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Ceftriaxone Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Ceftriaxone Market Size by Region
- 9.3.1 Asia-Pacific Ceftriaxone Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Ceftriaxone Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Ceftriaxone Sales Quantity by Type (2020-2031)
- 10.2 South America Ceftriaxone Sales Quantity by Application (2020-2031)
- 10.3 South America Ceftriaxone Market Size by Country
- 10.3.1 South America Ceftriaxone Sales Quantity by Country (2020-2031)
- 10.3.2 South America Ceftriaxone Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Ceftriaxone Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Ceftriaxone Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Ceftriaxone Market Size by Country
- 11.3.1 Middle East & Africa Ceftriaxone Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Ceftriaxone Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Ceftriaxone Market Drivers
- 12.2 Ceftriaxone Market Restraints
- 12.3 Ceftriaxone Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Ceftriaxone and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Ceftriaxone
- 13.3 Ceftriaxone Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Ceftriaxone Typical Distributors
- 14.3 Ceftriaxone Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Ceftriaxone. Industry analysis & Market Report on Ceftriaxone is a syndicated market report, published as Global Ceftriaxone Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Ceftriaxone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
